Larimar Therapeutics (LRMR) Profit After Tax: 2012-2019
Historic Profit After Tax for Larimar Therapeutics (LRMR) over the last 8 years, with Dec 2019 value amounting to -$45.4 million.
- Larimar Therapeutics' Profit After Tax rose 72.56% to -$3.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$35.9 million, marking a year-over-year increase of 38.67%. This contributed to the annual value of -$45.4 million for FY2019, which is 26.01% up from last year.
- According to the latest figures from FY2019, Larimar Therapeutics' Profit After Tax is -$45.4 million, which was up 26.01% from -$61.4 million recorded in FY2018.
- In the past 5 years, Larimar Therapeutics' Profit After Tax registered a high of -$45.4 million during FY2019, and its lowest value of -$74.3 million during FY2015.
- Its 3-year average for Profit After Tax is -$52.9 million, with a median of -$52.0 million in 2017.
- Per our database at Business Quant, Larimar Therapeutics' Profit After Tax plummeted by 103.65% in 2015 and then climbed by 26.01% in 2019.
- Over the past 5 years, Larimar Therapeutics' Profit After Tax (Yearly) stood at -$74.3 million in 2015, then climbed by 22.09% to -$57.9 million in 2016, then rose by 10.11% to -$52.0 million in 2017, then decreased by 17.95% to -$61.4 million in 2018, then climbed by 26.01% to -$45.4 million in 2019.